Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Next Generation Genomic (NGG) is a leading genetic diagnostic center based in Thailand, specializing in reproductive health and advanced genomic testing. The company provides a comprehensive suite of services including Preimplantation Genetic Testing for Aneuploidy (PGT-A), Non-Invasive Prenatal Testing (NIPT), and carrier screening for hereditary conditions. Utilizing Next-Generation Sequencing (NGS) technology, NGG supports fertility clinics and hospitals in improving clinical outcomes for IVF and prenatal care. The organization is recognized as a center of excellence in Southeast Asia for its high-quality laboratory standards and clinical genetics expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Next Generation Genomic.